← Leaderboards
Lakshmi Rajagopal
Seattle Children'S Hospital
$23,879,900
Attributed
$34,100,765
Total exposure
12
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $5.2M · FY2007–25$10M$7.5M$5M$2.5M$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$34,100,765 · 12
By mechanism
R01$32,527,538 · 9
R21$1,090,871 · 2
R56$482,356 · 1
Top collaborators
- Kristina M Adams Waldorf21 shared
- Adrian M Piliponsky5 shared
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- Adrian M Piliponsky$10,682,375
Others in their field
Top investigators on “Stillbirth”
- Corette B Parker · Research Triangle Institute$72,096,148
- Lisa P Jacobson · Johns Hopkins University$45,397,923
- Amy J Elliott · University Of South Dakota$39,992,564
- Diane J Catellier · Univ Of North Carolina Chapel Hill$15,650,428
- George R. Saade · Research Triangle Institute$14,182,219
- Kristina M Adams Waldorf · University Of Washington$12,612,551
Research focus
StillbirthStreptococcal InfectionsStreptococcus Group BInfectionPathogenBacterial InfectionsPreventPremature BirthCellsMediatingPregnancyMembraneSignal TransductionInjuryEarly OnsetNeonatalResponseIn UteroMorbidity - Disease RateBacteriaPathogenesisPregnantOrganismAmniotic Cavity
Grant awards (46)
Hyaluronidase mediated GBS Disease$3,613,118
R01 · FY2025 · AI · contact PI
Neutralizing the GBS hemolytic lipid toxin$1,620,448
R01 · FY2025 · AI · contact PI
Neutralizing the GBS hemolytic lipid toxin$846,792
R01 · FY2024 · AI · contact PI
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth$755,520
R01 · FY2024 · HD
FXIIIA production by mast cells for innate immunity$747,959
R01 · FY2024 · AI
Immune Control of Group B Streptococcal Placental$880,047
R01 · FY2023 · AI · contact PI
Neutralizing the GBS hemolytic lipid toxin$823,275
R01 · FY2023 · AI · contact PI
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth$768,194
R01 · FY2023 · HD
FXIIIA production by mast cells for innate immunity$755,460
R01 · FY2023 · AI
Immune Control of Group B Streptococcal Placental$891,373
R01 · FY2022 · AI · contact PI
Neutralizing the GBS hemolytic lipid toxin$805,917
R01 · FY2022 · AI · contact PI
FXIIIA production by mast cells for innate immunity$776,960
R01 · FY2022 · AI
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth$774,614
R01 · FY2022 · HD
Role of the hyaluronidase in GBS Virulence$904,350
R01 · FY2021 · AI · contact PI
Immune Control of Group B Streptococcal Placental$868,958
R01 · FY2021 · AI · contact PI
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth$770,043
R01 · FY2021 · HD
FXIIIA production by mast cells for innate immunity$717,609
R01 · FY2021 · AI
Role of the hyaluronidase in GBS Virulence$904,628
R01 · FY2020 · AI · contact PI
Immune Control of Group B Streptococcal Placental$891,718
R01 · FY2020 · AI · contact PI
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth$775,145
R01 · FY2020 · HD
FXIIIA production by mast cells for innate immunity$715,119
R01 · FY2020 · AI
Immune Control of Group B Streptococcal Placental$915,712
R01 · FY2019 · AI · contact PI
Role of the hyaluronidase in GBS Virulence$904,628
R01 · FY2019 · AI · contact PI
Role of the hyaluronidase in GBS Virulence$904,628
R01 · FY2018 · AI · contact PI
Role of an ornithine rhamnolipid pigment in GBS virulence$475,712
R01 · FY2018 · AI · contact PI
Role of the hyaluronidase in GBS Virulence$912,767
R01 · FY2017 · AI · contact PI
Role of an ornithine rhamnolipid pigment in GBS virulence$482,873
R01 · FY2017 · AI · contact PI
Role of human cervical mucus plugs in ascending GBS infection$233,701
R21 · FY2017 · AI · contact PI
GBS mediated in utero fetal injury$741,923
R01 · FY2016 · AI · contact PI
Role of an ornithine rhamnolipid pigment in GBS virulence$491,246
R01 · FY2016 · AI · contact PI
Role of human cervical mucus plugs in ascending GBS infection$304,497
R21 · FY2016 · AI · contact PI
GBS mediated in utero fetal injury$759,395
R01 · FY2015 · AI · contact PI
Role of an ornithine rhamnolipid pigment in GBS virulence$491,246
R01 · FY2015 · AI · contact PI
Environmental Signals that regulate GBS virulence$248,056
R21 · FY2015 · AI · contact PI
GBS mediated in utero fetal injury$771,648
R01 · FY2014 · AI · contact PI
Role of an ornithine rhamnolipid pigment in GBS virulence$458,250
R01 · FY2014 · AI · contact PI
Environmental Signals that regulate GBS virulence$304,617
R21 · FY2014 · AI · contact PI
GBS mediated in utero fetal injury$78,195
R01 · FY2014 · AI · contact PI
GBS mediated in utero fetal injury$740,566
R01 · FY2013 · AI · contact PI
Eukaryotic-signaling mediates two-component regulation of GBS virulence$482,356
R56 · FY2013 · AI · contact PI
GBS mediated in utero fetal injury$814,572
R01 · FY2012 · AI · contact PI
Eukaryotic-type signaling mediates two-component regulation of GBS virulence$393,726
R01 · FY2011 · AI · contact PI
Eukaryotic-type signaling mediates two-component regulation of GBS virulence$383,576
R01 · FY2010 · AI · contact PI
Eukaryotic-type signaling mediates two-component regulation of GBS virulence$407,561
R01 · FY2009 · AI · contact PI
Eukaryotic-type signaling mediates two-component regulation of GBS virulence$395,687
R01 · FY2008 · AI · contact PI
Eukaryotic-type signaling mediates two-component regulation of GBS virulence$396,380
R01 · FY2007 · AI · contact PI